Advertisement

Topics

ETCapital Limited Company Profile

08:21 EST 19th January 2019 | BioPortfolio

ETCapital Limited was set up in 1992 as an investor in high growth businesses based in southern England. Since 1998, ETCapital has invested QTP, a specialist zero-stage technology fund, focused on the globally significant cluster of science based businesses around Cambridge, Oxford and London. prior to that it managed what is now the HSBC UK Enterprise Fund for East Anglia & the Home Counties investing in early stage businesses, both technology and non-technology, based in East Anglia and the northern Home Counties.

Location

St John's Innovation Centre Cowley Road.
Cambridge
Cambridgeshire
CB4 0WS
United Kingdom

Contact

Phone: 01223 422010
Fax: 01223 422011
Email: martin@etcapital.com


News Articles [35 Associated News Articles listed on BioPortfolio]

Quotient Limited Announces Details of Investor Day

JERSEY, Channel Islands, July 16, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced details of its investor day held at the NASDAQ he...

Quotient Limited Announces Initial MosaiQ™ SDS Verification and Validation Data

JERSEY, Channel Islands, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today reported positive Verification and Validation...

Quotient Limited Announces Proposed Underwritten Offering of Ordinary Shares

JERSEY, Channel Islands, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the Company intends to commence an ...

Aleafia Health Completes Strategic Investment in Australia’s CannaPacific Pty Limited

Global Expansion Underway with 10% Equity Investment in Licensed Cannabis Cultivator CannaPacific among Australia’s only Federally Licensed Cultivators with projected 108,000 sq. ft. Greenhouse TO...

Quotient Limited to Participate in the Jefferies 2018 London Healthcare Conference

JERSEY, Channel Islands, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Quotient (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chief Financial Officer, Chris Lindop,...

Genetic Technologies Limited Announces New Biomedical Blockchain Joint Venture

MELBOURNE, Australia, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”), via its subsidiary Gene Ventures Pty Ltd, is pleased to announce that i...

Quotient Limited Announces Pricing of Underwritten Offering of Ordinary Shares

JERSEY, Channel Islands, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the pricing of its previously annou...

Genetic Technologies Limited Provides End of Year Update on the Test Development Program

MELBOURNE, Australia, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”), a diversified molecular diagnostics company embracing blockchain techno...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [86 Associated Companies listed on BioPortfolio]

ETCapital Limited

ETCapital Limited was set up in 1992 as an investor in high growth businesses based in southern England. Since 1998, ETCapital has invested QTP, a specialist zero-stage technology fund, focused on the...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

VASUDHA PHARMA CHEM LIMITED

VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...

More Information about "ETCapital Limited" on BioPortfolio

We have published hundreds of ETCapital Limited news stories on BioPortfolio along with dozens of ETCapital Limited Clinical Trials and PubMed Articles about ETCapital Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ETCapital Limited Companies in our database. You can also find out about relevant ETCapital Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record